About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

61.16 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 91
Open 61.16
Bid (Size) 60.96 (1)
Ask (Size) 61.58 (1)
Prev. Close 61.16
Today's Range 61.16 - 61.16
52wk Range 8.280 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Viking Therapeutics Stock Got Thrashed on Tuesday
A monster rival is making aggressive moves in one particular segment. 
Via The Motley Fool
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
The single-dose vials will also increase supply, the drug giant says. 
Via Investor's Business Daily

Performance

YTD
+234.57%
+234.57%
1 Month
-0.15%
-0.15%
3 Month
-4.15%
-4.15%
6 Month
-35.28%
-35.28%
1 Year
+341.59%
+341.59%

More News

Read More
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
Via The Motley Fool
Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now?
Via The Motley Fool
(VKTX) - Analyzing Viking Therapeutics's Short Interest
Via Benzinga
Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping?
Via Talk Markets
Unpacking the Latest Options Trading Trends in Viking Therapeutics
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $800 Today
Via Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Could Viking Therapeutics Become the Next Novo Nordisk?
Via The Motley Fool
3 Promising Biotech Stocks for the Long-Term: August 2024
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
Via The Motley Fool
Here's Why Eli Lilly Stock Dropped 12% Last Month
Via The Motley Fool
3 Unstoppable Stocks to Buy in August
Via The Motley Fool
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
Via The Motley Fool
What Are the Hottest Weight Loss Stocks Right Now? 3 Top Picks.
Via InvestorPlace
8 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma
Via The Motley Fool
3 Overlooked Stocks Poised for a Breakout Very Soon
Via InvestorPlace
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
Via The Motley Fool
Topics Economy
Exposures Interest Rates
The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.
Via The Motley Fool
Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.